Day: October 7, 2024

TORONTO, Oct. 07, 2024 (GLOBE NEWSWIRE) — Hudbay Minerals Inc. (“Hudbay” or the “company”) (TSX, NYSE: HBM) today announced that it has reached a final settlement with all plaintiffs in three civil lawsuits brought against the company regarding alleged actions that occurred in Guatemala in 2007 and 2009. This settlement concludes all outstanding legal matters related to Hudbay’s former activities in Guatemala. Hudbay was named in the civil suits because of its ownership of the Fenix nickel project, which was acquired in 2008. In one of the lawsuits, brought by 11 female plaintiffs, the allegations against the Guatemalan company that owns the project predate Hudbay’s ownership. In 2011, Hudbay divested itself of its holdings in Guatemala and has had no operations there since that time. “Hudbay is pleased to have reached a mutually...

Management Emphasizes That It Has Sufficient Cash to Achieve Its Goals Including Recently Announced Collaborations and Being Cash Flow Positive During 2025 The $11 Million Investment includes Leading Builders and Hotel Developers MIAMI, Oct. 07, 2024 (GLOBE NEWSWIRE) — SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), a highly disruptive smart platform technology company with more than 97 issued and pending patents globally and over 60 lighting and home décor websites, today announced the completion of a strategic investment of $11 million of a new class of preferred stock in SKYX, with a conversion price of $2.00 per common share, with an 8% annual dividend, led by Lance Shaner, Chairman & CEO of Shaner Hotel Group, joined by other strategic and key SKYX investors. Mr....

Geneva, Switzerland, Oct. 07, 2024 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology hardware and software products, today announced that its technology and solutions support the IoMT segment by providing key security components for applications able to secure communications and authenticate devices. While the IoMT continues to revolutionize healthcare, the integration of advanced security measures becomes paramount to protect sensitive data and maintain the integrity of medical systems. The IoMT represents a vast network of interconnected medical devices, sensors, software, and healthcare systems utilizing internet connectivity to exchange information. By leveraging technologies like wireless...

NEW YORK, Oct. 07, 2024 (GLOBE NEWSWIRE) — Inspired Entertainment, Inc. (“Inspired” or the “Company”) (NASDAQ: INSE), a leading B2B provider of gaming content, technology, hardware, and services, is excited to announce the upgrade of 4,000 Video Lottery Terminals (VLTs) for its long-term partner, OPAP, Greece’s leading gaming company. As OPAP’s largest VLT supplier, with more than 9,400 machines already in the market, Inspired will provide 4,000 of its latest VLTs, including the global launch of the innovative Valor Slant VLT. The Valor Slant is a standout addition to Inspired’s successful Valor family, designed exclusively for the Greek market, aiming to deliver an exceptional gaming experience. Featuring dual 32-inch HD screens, it combines stunning visuals with advanced technology and immersive sound, creating an...

ATHENS, Greece, Oct. 07, 2024 (GLOBE NEWSWIRE) — Euroseas Ltd. (NASDAQ: ESEA, the “Company” or “Euroseas”), an owner and operator of container carrier vessels and provider of seaborne transportation for containerized cargoes, announced today a time charter contract for its 1,732 teu feeder containership, M/V Jonathan P, for a minimum period of 11 to a maximum period of 13 months at the option of the charterer, at a gross daily rate of $20,000. The new charter will commence after the completion of her scheduled intermediate survey, expected around mid-to-end of October 2024. Aristides Pittas, Chairman and CEO of Euroseas commented: ”We are pleased to announce that our 18-year-old M/V Jonathan P has been chartered with a top-class charterer for 11-13 months, at a profitable rate of $20,000/day. This fixture is a testament to the...

FORT WORTH, TX, Oct. 07, 2024 (GLOBE NEWSWIRE) — Sanara MedTech Inc. — Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI), a medical technology company focused on improving clinical outcomes and reducing healthcare expenditures in the surgical, chronic wound and skincare markets announced today changes to its Board of Directors (“Board”). After a long tenure of service with the predecessor company and Sanara, Mr. James “Jim” Stuckert has resigned from his position as a director, and Mr. Keith Myers has been appointed to serve as a director on the Board in order to fill the vacancy resulting from Mr. Stuckert’s resignation. Mr. Stuckert will continue to serve the Board as Director Emeritus. Ron Nixon, Sanara’s Executive Chairman and CEO, stated, “I want to thank Jim for his leadership...

Reykjavik, Oct. 07, 2024 (GLOBE NEWSWIRE) — (“Amaroq” or the “Company”) Director/PDMR Shareholding – Notification of Transactions of Directors/Persons Discharging Managerial Responsibilities (PDMRs) TORONTO, ONTARIO – October 7, 2024 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mine development company with a substantial land package of gold and strategic mineral assets in Southern Greenland, announces that it was informed that Eldur Olafsson, CEO of Amaroq Minerals, acquired a total of 300,000 common shares of no par value in the Company. This brings Eldur Olafsson’s indirect total holding to 9,502,173 shares, 2.9% of the capital in the Company. DEALING NOTIFICATION FORM FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS1. Details of the person...

7 October 2024, Erste Group, one off the largest banking groups in Central and Eastern Europe (CEE) region, has initiated sponsored research of AB Šiaulių Bankas at Buy rating and published the initiation of coverage research. Analysis suggests a target price of EUR 1.00. The research highlights that Šiaulių Bankas presents an attractive investment opportunity due to its position in Lithuania’s structurally strong economy and a banking market with significant growth potential. The Bank’s strategic focus on high-margin lending segments like SME and consumer finance allows for above-average returns. Research further highlights that investors will also be drawn to the Bank’s solid capitalization, which supports an increased dividend payout ratio (minimum 50% under the new policy) and share buybacks, offering strong total shareholder returns....

MIAMI, Oct. 07, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that Wa’el Hashad, Chief Executive Officer of Longeveron will participate in a Fireside Chat at the UBS Virtual Organ Restoration and Cell Therapy Day, taking place virtually October 15, 2024. Fireside chat with Ash Verma, SMID-cap Biotech & Specialty Pharma Analyst, UBS Equity Research:  Date: Tuesday, October 15, 2024  Time: 3:00 p.m. – 3:45 p.m. ET     To register for the event, please contact your UBS representative. The Longeveron investor presentation is available at the “Events & Presentations” section of the Company’s website. About Longeveron Inc. Longeveron is a...

LEXINGTON, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ: TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has entered into a multi-year exclusive U.S. agreement with Cardinal Health (NYSE: CAH),. Under the agreement, Cardinal Health will have exclusive rights to sell T2 Biosystems’ FDA-cleared direct-from-blood diagnostics for the rapid detection of sepsis-causing pathogens, including the T2Dx® Instrument, the T2Bacteria® Panel, and the T2Candida® Panel. “We are thrilled to have entered into a distribution agreement with Cardinal Health that will make them the exclusive distributor of our FDA-cleared direct-from-blood diagnostics in the United States which will dramatically increase our representation with hospital...